Type your tag names separated by a space and hit enter
Temozolomide for high grade glioma
There's more to see -- the rest of this topic is available only to subscribers.
"Temozolomide for High Grade Glioma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma. Accessed 24 September 2023.
Temozolomide for high grade glioma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma. Accessed September 24, 2023.
Temozolomide for high grade glioma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma
Temozolomide for High Grade Glioma [Internet]. In: Cochrane Abstracts. [cited 2023 September 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Temozolomide for high grade glioma
ID - 435511
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435511/all/Temozolomide_for_high_grade_glioma
DB - Evidence Central
DP - Unbound Medicine
Try the app for free!
1. Download the Evidence Central app by Unbound Medicine
2. Select Try/Buy and follow instructions to begin your free 30-day trial
You can cancel anytime within the 30-day trial, or continue using Evidence Central to begin a 1-year subscription ($39.95)
Your free 1 year of online access expired .
Want to regain access to Evidence Central?
Log in to Evidence Central
If you need further assistance, please contact Support.